Clinical Study to Investigate the Pharmacokinetics of Multiple Repeated Doses of Intranasal Naloxone
Clinical trial NCT04764630 · COMPLETED
Trial details
- NCT number
- NCT04764630
- Sponsor
- Food and Drug Administration (FDA)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-01
- Primary completion
- 2021-03-20
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.